Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margit Fisch

Showing results (281-290 of 336) with videos related to

Pageof 34
Sort By:
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
BJA Open|July 25, 2024
Personalised blood pressure management during major noncardiac surgery and postoperative neurocognitive disorders: a randomised trialJulia Y Nicklas, Alina Bergholz, Francesco Däke, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Pageof 34

Showing results (281-290 of 336) with videos related to

Sort By:
Pageof 34
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
BJA Open|July 25, 2024
Personalised blood pressure management during major noncardiac surgery and postoperative neurocognitive disorders: a randomised trialJulia Y Nicklas, Alina Bergholz, Francesco Däke, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Pageof 34